Ina Rhee - Researcher Profile | RDL Research Database

Publications

2 shown

Clinical activity, safety, and biomarkers of MPDL3280A, an engineered PD-L1 antibody in patients with metastatic renal cell carcinoma (mRCC).

Daniel C. Cho , Jeffrey A. Sosman , Mario Sznol +11 more

4505 Background: Human RCC expresses PD-L1 and has been shown to respond to immune-based therapy. MPDL3280A, a human monoclonal antibody containing an engineered Fc-domain desig...

2013 Journal of Clinical Oncology 97 citations

Personalized RNA neoantigen vaccines stimulate T cells in pancreatic cancer

Luis A. Rojas , Zachary Sethna , Kevin C. Soares +48 more

Abstract Pancreatic ductal adenocarcinoma (PDAC) is lethal in 88% of patients 1 , yet harbours mutation-derived T cell neoantigens that are suitable for vaccines 2,3 . Here in a...

2023 Nature 996 citations

Frequent Co-Authors

Researcher Info

h-index: 2
Publications: 2
Citations: 1,093

External Links

Google Scholar

Impact Metrics

h-index 2

h-index: Number of publications with at least h citations each.